<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04138966</url>
  </required_header>
  <id_info>
    <org_study_id>P2019/427Am1</org_study_id>
    <nct_id>NCT04138966</nct_id>
  </id_info>
  <brief_title>Comparing Skin Conductance, Analgesia-nociception-index, and Nol-index</brief_title>
  <official_title>Nociceptive Monitoring With Skin Conductance, Analgesia-nociception-index, and Nol-index in Moderate-to-high Risk Cardiovascular Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison of three different nociception monitors during general anesthesia
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Analgesia remains a challenge in anesthesia. Several monitors have shown potential in
      detecting insufficient analgesia during general anesthesia, but they have not been
      investigated in patients undergoing cardiac and vascular surgery. In this study, we will
      compare skin conductance (Medstorm, Norway), analgesia-nociception-index (MDoloris, France)
      and nol-index (Medasense, Israel) w during noxious and non-noxious stimuli. This study is
      carried out on patients included in another study (Nol-Index Guided Remifentanil Analgesia
      Versus Standard Analgesia During Moderate-to-High Risk Cardiovascular Surgery).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2019</start_date>
  <completion_date type="Anticipated">June 20, 2020</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Nol-Index response</measure>
    <time_frame>1 to 2 hours</time_frame>
    <description>Nol-Index (diminsenliss value from 0 to 100) will be assessed during noxious and non noxious stimuli</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analgesia-Nociception-Index response</measure>
    <time_frame>1 to 2 hours</time_frame>
    <description>ANI (dimensionless value from 0 to 100) will be assessed during noxious and non noxious stimuli</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin conductance response</measure>
    <time_frame>1 to 2 hours</time_frame>
    <description>Peaks per second change during noxious and non noxious stimuli</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Analgesia</condition>
  <condition>Anesthesia</condition>
  <condition>Monitoring</condition>
  <condition>Vascular Diseases</condition>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Patients undergoing general anesthesia</arm_group_label>
    <description>Patients are monitored with Nol-Index, skin conductance, and antinociception-index</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nol-Index</intervention_name>
    <description>Multiparametric monitor that studies that establishes an index as a surrogate to nociception</description>
    <arm_group_label>Patients undergoing general anesthesia</arm_group_label>
    <other_name>PMD-200</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Skin Conductance</intervention_name>
    <description>Measures skin conductance as a surrogate to nociception</description>
    <arm_group_label>Patients undergoing general anesthesia</arm_group_label>
    <other_name>The PainMonitor Index</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Analgesia-Nociception-Index</intervention_name>
    <description>Analysis of the heart rates parasympathetic component via the respiratory sinus arrhythmia reflex as a surrogate to nociception</description>
    <arm_group_label>Patients undergoing general anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiac or vascular surgery
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  moderate-to-high risk cardiac or vascular surgery

          -  ASA 2-4

        Exclusion Criteria:

          -  chronic arrhythmia (e.g. atrial fibrillation)

          -  aortic insufficiency

          -  pacemaker

          -  implanted defibrillator

          -  valve surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Luc Barvais, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anesthesia Department, Erasme Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sean Coeckelenbergh, MD</last_name>
    <phone>32 (0) 2 555 39 19</phone>
    <email>secoecke@ulb.ac.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luc Barvais, MD, PhD</last_name>
    <phone>32 (0) 2 555 39 19</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anesthesia Department, Erasme Hospital</name>
      <address>
        <city>Brussels</city>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sean Coeckelenbergh, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 23, 2019</study_first_submitted>
  <study_first_submitted_qc>October 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

